What is the price target for MDT stock?
38 analysts have analysed MDT and the average price target is 113.25 USD. This implies a price increase of 29.38% is expected in the next year compared to the current price of 87.53.
NYSE:MDT • IE00BTN1Y115
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDTRONIC PLC (MDT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-10 | Needham | Reiterate | Buy -> Buy |
| 2026-02-18 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2026-02-18 | Baird | Maintains | Neutral -> Neutral |
| 2026-02-17 | Needham | Maintains | Buy -> Buy |
| 2026-02-13 | Barclays | Reiterate | Overweight -> Overweight |
| 2026-02-09 | Needham | Upgrade | Hold -> Buy |
| 2026-01-09 | Bernstein | Maintains | Outperform -> Outperform |
| 2026-01-08 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-06 | William Blair | Upgrade | Market Perform -> Outperform |
| 2025-12-18 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-20 | Truist Securities | Maintains | Hold -> Hold |
| 2025-11-19 | UBS | Maintains | Neutral -> Neutral |
| 2025-11-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-19 | Baird | Maintains | Neutral -> Neutral |
| 2025-11-19 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-11-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-13 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-15 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-09 | Stifel | Maintains | Hold -> Hold |
| 2025-10-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-08-26 | Argus Research | Maintains | Buy -> Buy |
| 2025-08-21 | Truist Securities | Maintains | Hold -> Hold |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.227B -1.45% | 32.364B 3.64% | 33.537B 3.62% | 36.526B 8.91% | 38.978B 6.71% | 40.965B 5.10% | 43.158B 5.35% | 45.325B 5.02% | |
| EBITDA YoY % growth | 9.043B -5.93% | 8.768B -3.04% | 9.436B 7.62% | 10.366B 9.86% | 11.181B 7.86% | 12.033B 7.62% | 13.041B 8.38% | 13.981B 7.21% | |
| EBIT YoY % growth | 6.346B -8.11% | 6.121B -3.55% | 6.575B 7.42% | 9.162B 39.35% | 9.85B 7.51% | 10.551B 7.12% | 11.331B 7.39% | 12.199B 7.66% | |
| Operating Margin | 20.32% | 18.91% | 19.61% | 25.08% | 25.27% | 25.76% | 26.25% | 26.91% | |
| EPS YoY % growth | 5.30 -5.69% | 5.21 -1.70% | 5.50 5.57% | 5.70 3.55% | 6.14 7.81% | 6.61 7.73% | 7.18 8.48% | 7.75 7.99% |
All data in USD
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.68 3.46% | 1.40 10.86% | 1.47 8.29% | 1.49 9.36% | 1.82 8.76% | 1.48 6.15% | 1.55 5.27% | 1.58 6.48% | 1.97 7.88% |
| Revenue Q2Q % growth | 9.747B 9.19% | 9.448B 10.65% | 9.522B 6.26% | 9.481B 5.15% | 10.264B 5.30% | 9.5B 0.55% | 9.991B 4.93% | 9.954B 4.99% | 10.848B 5.69% |
| EBITDA Q2Q % growth | 3.043B -34.69% | 2.548B 11.46% | 2.654B -16.85% | 2.714B -31.12% | 3.27B 7.46% | 2.723B 6.87% | 2.803B 5.61% | 2.991B 10.21% | 3.367B 2.97% |
| EBIT Q2Q % growth | 2.738B 52.28% | 2.25B 46.29% | 2.368B 39.38% | 2.386B 40.52% | 2.94B 7.38% | 2.408B 7.02% | 2.478B 4.65% | 2.603B 9.09% | 3.119B 6.09% |
All data in USD
38 analysts have analysed MDT and the average price target is 113.25 USD. This implies a price increase of 29.38% is expected in the next year compared to the current price of 87.53.
MEDTRONIC PLC (MDT) will report earnings on 2026-05-20, after the market close.
The consensus EPS estimate for the next earnings of MEDTRONIC PLC (MDT) is 1.68 USD and the consensus revenue estimate is 9.75B USD.
The number of analysts covering MEDTRONIC PLC (MDT) is 38.